http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103534272-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate | 2012-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103534272-B |
| titleOfInvention | Antibody that can specific recognition TfR |
| abstract | The object of the present invention is to provide a kind of specific recognition people TfR, suppress existence and the propagation of the cancer cell of TfR high expressed, and people is not had to the anti-human TfR antibody of immunogenic complete people. According to the present invention, the antibody that provides a kind of and people TfR to carry out specific reaction, as heavy chain the first complementary determining region (VH? CDR1), heavy chain the second complementary determining region (VH? CDR2), heavy chain the 3rd complementary determining region (VH? CDR3) comprise respectively the amino acid sequence arbitrarily in sequence number 1～3,7～9,13～15,19～21,25～27,31～33,37～39,43～45,49～51,55～57,61～63,67～69,73～75,79～81,85～87,91～93,97～99,103～105,109～111,115～117. |
| priorityDate | 2011-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 188.